Paulsen Gisela's Form 4 filing
Insight Molecular Diagnostics Inc. (IMDX) · filed Mar 17, 2022
- Accession no.
- 0001493152-22-007206
- Filed
- Mar 17, 2022
- Trade date
- Mar 15-17, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 2 derivative transactions. Open-market purchases total $19.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Paulsen GiselaCIK 0001807104 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 | Common Stock, no par value | PPurchaseAcquired | +16,500 | $1.20 | +$19,800 | 16,500 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2022 | Common Stock | AGrant or awardAcquired | +125,000 | $0.00 | $0 | 125,000 | Direct | |
| Mar 15, 2022 | Common Stock | AGrant or awardAcquired | +125,000 | $0.00 | $0 | 125,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.